SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bajaj Healthcare - Quaterly Results

17 Jan 2026 Evaluate
The sales for the December 2025 quarter moved up 31.30% to Rs. 1612.23 millions as compared to Rs. 1227.94 millions during the corresponding quarter last year.A slim rise of 7.58% was recorded in the Net profit for the quarter ended December 2025 to Rs. 161.00  millions  From Rs. 149.66 millions.OP of the company witnessed a marginal growth to 323.29 millions from 240.12 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 1612.23 1227.94 31.30 4579.74 3881.30 18.00 5426.02 4734.18 14.61
Other Income 16.47 23.72 -30.56 41.78 58.33 -28.37 194.04 86.86 123.39
PBIDT 323.29 240.12 34.64 863.20 765.00 12.84 1018.31 849.51 19.87
Interest 58.84 55.09 6.81 166.69 218.29 -23.64 279.04 296.80 -5.98
PBDT 264.45 185.03 42.92 696.51 546.71 27.40 739.27 109.43 575.56
Depreciation 72.01 68.50 5.12 199.19 203.86 -2.29 279.18 276.20 1.08
PBT 192.44 116.53 65.14 497.32 342.85 45.05 460.09 -166.77 -375.88
TAX 31.44 -33.13 -194.90 90.09 29.50 205.39 30.79 -23.49 -231.08
Deferred Tax 31.44 -33.13 -194.90 90.09 29.50 205.39 30.79 -37.05 -183.10
PAT 161.00 149.66 7.58 407.23 313.35 29.96 429.30 -143.28 -399.62
Equity 157.92 157.92 0.00 157.92 157.92 0.00 157.92 137.99 14.44
PBIDTM(%) 20.05 19.55 2.55 18.85 19.71 -4.37 18.77 17.94 4.59

Bajaj Healthcare Share Price

335.65 11.60 (3.58%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×